Alirocumab reduces total nonfatal cardiovascular and fatal events: The ODYSSEY OUTCOMES trial
Journal of the American College of Cardiology | Feb 01, 2019
Generic and brand-name thyroid hormone drug use among commercially-insured and Medicare beneficiaries, 2007-2016
Journal of Clinical Endocrinology and Metabolism | Jan 31, 2019
Most read this week